Annals of Oncology 10:663-669, 1999
© 1999 European Society for Medical Oncology
research-article |
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
1Centre de Chronothérapie, Fédération des Maladies Sanguines Imnumitaires el Tumorales, Service d'Oncologie Médicate France
2Centre Hépato-biliaire France
3Service d'Anatomie Pathologique, Hôpital Paul Brousse Villejuif, France
S. Giacchetti, MD, Laboratoire Rythmes Biologiques et Chronotherapeutique (I.C.I G.), Hôpital Paul Brousse, 14 Avenue P.V. Couturier, 94807 Villejuif, France
Context: Long-term survival of patients with metastatic colorectal cancer has been achieved only in patients who underwent complete resection of metastases. Such surgery could be performed in a greater proportion of patients if effective chemotherapy could downstage previously unresectable metastases. This approach has been limited by the low tumor response rate achieved with conventional chemotherapy.
Objective: We studied the outcome of patients with initially unresectable liver metastases from colorectal cancer treated with a three-drug chemotherapy regimen followed by liver metastases surgery whenever possible.
Patients and methods: From March 1988 to June 1994, 151 patients with colorectal liver metastases were considered initially unresectable because of large tumor size (>5 cm), multi-nodular (>4) or ill-located metastases. All patients received fully ambulatory chemotherapy with 5-fluorouracil, leucovorin and oxaliplatin (chronotherapy in 83% of them). They were periodically reassessed for surgery by a joint medico-surgical team.
Results: In 151 patients, the size of liver metastases decreased by > 50% in 89 patients (59%) and median overall survival was 24 months (95% confidence interval (95% CI): 19–28 months), with 28% surviving at five years (20%–35%). Surgery with curative intent was attempted in 77 patients (51%), complete resection of liver metastases was achieved in 58 patients (38%). The median survival of the 77 operated patients was 48 months (25–71), with a five-year survival rate of 50% (38–61).
Conclusion: This new strategy of combining effective chemotherapy with surgery apparently altered the natural history of unresectable colorectal cancer metastases.
chronotherapy, colorectal cancer, liver metastases, oxaliplatin, surgery, survival
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Nordlinger, E. Van Cutsem, T. Gruenberger, B. Glimelius, G. Poston, P. Rougier, A. Sobrero, M. Ychou, and on behalf of the European Colorectal Metastases Tr Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Ann. Onc., June 1, 2009; 20(6): 985 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Adam, D. A. Wicherts, R. J. de Haas, O. Ciacio, F. Levi, B. Paule, M. Ducreux, D. Azoulay, H. Bismuth, and D. Castaing Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure? J. Clin. Oncol., April 10, 2009; 27(11): 1829 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Adam and T. A. Aloia In Reply J. Clin. Oncol., March 10, 2009; 27(8): 1343 - 1345. [Full Text] [PDF]
|
|
|
|
|
|
D. Papamichael, R. Audisio, J.-C. Horiot, B. Glimelius, J. Sastre, E. Mitry, E. Van Cutsem, M. Gosney, C.-H. Kohne, and M. Aapro Treatment of the elderly colorectal cancer patient: SIOG expert recommendations Ann. Onc., January 1, 2009; 20(1): 5 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Poston, J. Figueras, F. Giuliante, G. Nuzzo, A. F. Sobrero, J.-F. Gigot, B. Nordlinger, R. Adam, T. Gruenberger, M. A. Choti, et al. Urgent Need for a New Staging System in Advanced Colorectal Cancer J. Clin. Oncol., October 10, 2008; 26(29): 4828 - 4833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Capussotti, A. Muratore, F. Baracchi, B. Lelong, A. Ferrero, D. Regge, and J. R. Delpero Portal Vein Ligation as an Efficient Method of Increasing the Future Liver Remnant Volume in the Surgical Treatment of Colorectal Metastases Arch Surg, October 1, 2008; 143(10): 978 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Alberts and L. D. Wagman Chemotherapy for Colorectal Cancer Liver Metastases Oncologist, October 1, 2008; 13(10): 1063 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Adam, R. J. de Haas, D. A. Wicherts, T. A. Aloia, V. Delvart, D. Azoulay, H. Bismuth, and D. Castaing Is Hepatic Resection Justified After Chemotherapy in Patients With Colorectal Liver Metastases and Lymph Node Involvement? J. Clin. Oncol., August 1, 2008; 26(22): 3672 - 3680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Adam, D. A. Wicherts, R. J. de Haas, T. Aloia, F. Levi, B. Paule, C. Guettier, F. Kunstlinger, V. Delvart, D. Azoulay, et al. Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality? J. Clin. Oncol., April 1, 2008; 26(10): 1635 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tabernero, E. Van Cutsem, E. Diaz-Rubio, A. Cervantes, Y. Humblet, T. Andre, J.-L. Van Laethem, P. Soulie, E. Casado, C. Verslype, et al. Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer J. Clin. Oncol., November 20, 2007; 25(33): 5225 - 5232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Adam, T. Aloia, F. Levi, D. A. Wicherts, R. J. de Haas, B. Paule, M.-P. Bralet, M. Bouchahda, D. Machover, M. Ducreux, et al. Hepatic Resection After Rescue Cetuximab Treatment for Colorectal Liver Metastases Previously Refractory to Conventional Systemic Therapy J. Clin. Oncol., October 10, 2007; 25(29): 4593 - 4602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kemeny Presurgical Chemotherapy in Patients Being Considered for Liver Resection Oncologist, July 1, 2007; 12(7): 825 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ahmad, S. L. Chen, and A. J. Bilchik Role of Repeated Hepatectomy in the Multimodal Treatment of Hepatic Colorectal Metastases Arch Surg, June 1, 2007; 142(6): 526 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Falcone, S. Ricci, I. Brunetti, E. Pfanner, G. Allegrini, C. Barbara, L. Crino, G. Benedetti, W. Evangelista, L. Fanchini, et al. Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest J. Clin. Oncol., May 1, 2007; 25(13): 1670 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Giacchetti, T. Gorlia, C. Garufi, and F. Levi In Reply J. Clin. Oncol., February 10, 2007; 25(5): 606 - 607. [Full Text] [PDF]
|
|
|
|
|
|
D. Gholam, S. Giacchetti, C. Brezault-Bonnet, M. Bouchahda, D. Hauteville, R. Adam, B. Ducot, O. Ghemard, F. Kustlinger, C. Jasmin, et al. Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer Oncologist, November 1, 2006; 11(10): 1072 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Poston, R. Adam, and J.-N. Vauthey Downstaging or Downsizing: Time for a New Staging System in Advanced Colorectal Cancer? J. Clin. Oncol., June 20, 2006; 24(18): 2702 - 2706. [Full Text] [PDF]
|
|
|
|
|
|
R. Glynne-Jones, J. Dunst, and D. Sebag-Montefiore The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? Ann. Onc., March 1, 2006; 17(3): 361 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Poston, R. Adam, S. Alberts, S. Curley, J. Figueras, D. Haller, F. Kunstlinger, G. Mentha, B. Nordlinger, Y. Patt, et al. OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer J. Clin. Oncol., October 1, 2005; 23(28): 7125 - 7134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Andre and W Schmiegel CHEMORADIOTHERAPY FOR COLORECTAL CANCER Gut, August 1, 2005; 54(8): 1194 - 1202. [Full Text] [PDF]
|
|
|
|
|
|
G. Folprecht, A. Grothey, S. Alberts, H.-R. Raab, and C.-H. Kohne Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann. Onc., August 1, 2005; 16(8): 1311 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Leonard, B. Brenner, and N. E. Kemeny Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal Carcinoma J. Clin. Oncol., March 20, 2005; 23(9): 2038 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Poston Radiofrequency Ablation of Colorectal Liver Metastases: Where Are We Really Going? J. Clin. Oncol., March 1, 2005; 23(7): 1342 - 1344. [Full Text] [PDF]
|
|
|
|
|
|
M. Schindl, S. J. Wigmore, E. J. Currie, F. Laengle, and O. J. Garden Prognostic Scoring in Colorectal Cancer Liver Metastases: Development and Validation Arch Surg, February 1, 2005; 140(2): 183 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Masi, G. Allegrini, S. Cupini, L. Marcucci, E. Cerri, I. Brunetti, E. Fontana, S. Ricci, M. Andreuccetti, and A. Falcone First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule Ann. Onc., December 1, 2004; 15(12): 1766 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Folprecht, D. Cunningham, P. Ross, B. Glimelius, F. Di Costanzo, J. Wils, W. Scheithauer, P. Rougier, E. Aranda, H. Hecker, et al. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials Ann. Onc., September 1, 2004; 15(9): 1330 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Maindrault-Goebel, C. Tournigand, T. Andre, E. Carola, M. Mabro, P. Artru, C. Louvet, and A. de Gramont Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer Ann. Onc., August 1, 2004; 15(8): 1210 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pozzo, M. Basso, A. Cassano, M. Quirino, G. Schinzari, N. Trigila, M. Vellone, F. Giuliante, G. Nuzzo, and C. Barone Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients Ann. Onc., June 1, 2004; 15(6): 933 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Diaz-Rubio New Chemotherapeutic Advances in Pancreatic, Colorectal, and Gastric Cancers Oncologist, June 1, 2004; 9(3): 282 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Chau, M. J. Allen, D. Cunningham, A. R. Norman, G. Brown, H. E.R. Ford, N. Tebbutt, D. Tait, M. Hill, P. J. Ross, et al. The Value of Routine Serum Carcino-Embryonic Antigen Measurement and Computed Tomography in the Surveillance of Patients After Adjuvant Chemotherapy for Colorectal Cancer J. Clin. Oncol., April 15, 2004; 22(8): 1420 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rubbia-Brandt, V. Audard, P. Sartoretti, A. D. Roth, C. Brezault, M. Le Charpentier, B. Dousset, P. Morel, O. Soubrane, S. Chaussade, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann. Onc., March 1, 2004; 15(3): 460 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Vogl, R. Straub, K. Eichler, O. Sollner, and M. G. Mack Colorectal Carcinoma Metastases in Liver: Laser-induced Interstitial Thermotherapy--Local Tumor Control Rate and Survival Data Radiology, February 1, 2004; 230(2): 450 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rodel, Gerhard. G. Grabenbauer, T. Papadopoulos, W. Hohenberger, H.-J. Schmoll, and R. Sauer Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer J. Clin. Oncol., August 15, 2003; 21(16): 3098 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Falcone, G. Masi, G. Allegrini, R. Danesi, E. Pfanner, I. M. Brunetti, A. Di Paolo, S. Cupini, M. Del Tacca, and P. Conte Biweekly Chemotherapy With Oxaliplatin, Irinotecan, Infusional Fluorouracil, and Leucovorin: A Pilot Study in Patients With Metastatic Colorectal Cancer J. Clin. Oncol., October 1, 2002; 20(19): 4006 - 4014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Price, C. Karapetis, V. Chevalier, H. Cure, P. Chollet, and F. Levi Chronomodulated Chemotherapy in Advanced Colorectal Carcinoma J. Clin. Oncol., September 15, 2002; 20(18): 3937 - 3939. [Full Text] [PDF]
|
|
|
|
|
|
S. Cascinu, V. Catalano, L. Cordella, R. Labianca, P. Giordani, A. M. Baldelli, G. D. Beretta, E. Ubiali, and G. Catalano Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial J. Clin. Oncol., August 15, 2002; 20(16): 3478 - 3483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Gornet, E. Savier, F. Lokiec, E. Cvitkovic, J. -L. Misset, and F. Goldwasser Exacerbation of oxaliplatin neurosensory toxicity following surgery Ann. Onc., August 1, 2002; 13(8): 1315 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Seitz, J. Bennouna, B. Paillot, E. Gamelin, E. Francois, T. Conroy, J.-L. Raoul, Y. Becouarn, F. Bertheault-Cvitkovic, M. Ychou, et al. Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients Ann. Onc., July 1, 2002; 13(7): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nordlinger and P. Rougier Liver Metastases From Colorectal Cancer: The Turning Point J. Clin. Oncol., March 15, 2002; 20(6): 1442 - 1445. [Full Text] [PDF]
|
|
|
|
|
|
H. Cure, V. Chevalier, A. Adenis, N. Tubiana-Mathieu, G. Niezgodzki, F. Kwiatkowski, D. Pezet, B. Perpoint, B. Coudert, C. Focan, et al. Phase II Trial of Chronomodulated Infusion of High-Dose Fluorouracil and l-Folinic Acid in Previously Untreated Patients With Metastatic Colorectal Cancer J. Clin. Oncol., March 1, 2002; 20(5): 1175 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Giacchetti, B. Perpoint, R. Zidani, N. Le Bail, R. Faggiuolo, C. Focan, P. Chollet, J. F. Llory, Y. Letourneau, B. Coudert, et al. Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil-Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer J. Clin. Oncol., January 5, 2000; 18(1): 136 - 136. [Abstract] [Full Text] [PDF]
|
|